Vertaling van "driven by sustained pharmaceuticals innovation " (Nederlands → Frans) :

Novartis delivers strong operational performance in the first half of 2009 driven by sustained Pharmaceuticals innovation
Novartis: excellente performance opérationnelle au premier semestre 2009, entraînée par les innovations soutenues de Pharmaceuticals

Pharmaceuticals: +10% (+5% lc) to USD 26.3 billion Accelerating momentum in Pharmaceuticals in 2008 was driven by ongoing dynamic growth in Oncology, sustained expansion of the cardiovascular portfolio and USD 2.9 billion of contributions in 2008 from recently launched products including Aclasta/Reclast, Tekturna/Rasilez, Exforge, Exjade, Lucentis, Exelon Patch, Tasigna and Xolair.
Pharmaceuticals: +10% (+5% en m. l) à USD 26,3 milliards L’accélération de Pharmaceuticals est due à la poursuite d’une croissance dynamique continue d’Oncologie, par une expansion soutenue du portefeuille de Cardiovasculaire et par des contributions à hauteur d'USD 2.9 milliards en 2008 de produits lancés récemment, notamment Aclasta/Reclast, Rasilez/Tekturna, Exforge, Exjade, Lucentis, Exelon Patch, Tasigna et Xolair.

Pharmaceuticals: USD 7.8 billion (+21%, +13% lc) Sustained dynamic growth in the 2009 fourth quarter driven by rapid uptake of new products and ongoing expansion in all major markets.
Pharmaceuticals: USD 7,8 milliards (+21%, +13% en m. l).